
Rekonnect
Commercial Intelligence Suite for MedTech, enhancing post market activities, partnerships, and data insights.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor | €0.0 | round |
* | SEK4.6m | Seed | |
Total Funding | 000k |
SEK | 2022 | 2023 | 2024 |
---|---|---|---|
Revenues | 0000 | 0000 | 0000 |
% growth | - | 143 % | 78 % |
EBITDA | 0000 | 0000 | 0000 |
Profit | 0000 | 0000 | 0000 |
% profit margin | (123 %) | (255 %) | (113 %) |
EV | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
Rekonnect.io is a forward-thinking startup that operates in the MedTech (Medical Technology) sector. The company offers a sophisticated Commercial Intelligence Suite designed to streamline and enhance post-market activities for medical device manufacturers. This platform is particularly beneficial for MedTech companies looking to improve their sales cycles, reduce misuse rates, and increase brand recognition.
Rekonnect.io serves a diverse range of clients within the healthcare industry, primarily focusing on medical device manufacturers. These clients benefit from the platform's ability to move high-value leads through the sales funnel more efficiently, thereby shortening the sales cycle. Additionally, the platform helps reduce the risk of misuse and malfunction of medical devices by healthcare professionals, which is crucial for maintaining safety and efficacy.
The market Rekonnect.io operates in is highly specialized and competitive, focusing on post-market surveillance and commercial intelligence within the MedTech landscape. This market is driven by the need for continuous improvement in medical device performance and compliance with regulatory standards.
The business model of Rekonnect.io revolves around providing a subscription-based software platform. Clients pay for access to the suite, which offers features like automation and trend analysis of post-market data, coordination of post-market activities, and tools to strengthen partnerships and extract valuable insights. This model ensures a steady revenue stream while providing clients with ongoing value through continuous updates and support.
Rekonnect.io makes money by charging subscription fees for its platform. These fees are justified by the significant benefits the platform provides, such as faster sales cycles, reduced misuse rates, and enhanced brand visibility. By leveraging comprehensive market data, the platform enables clients to make informed decisions and stay ahead in the dynamic MedTech market.
In summary, Rekonnect.io is revolutionizing the post-market approach for MedTech companies by offering a powerful platform that enhances efficiency, safety, and market positioning.
Keywords: MedTech, post-market, sales cycles, misuse reduction, brand recognition, automation, trend analysis, commercial intelligence, healthcare, medical devices.